HK1029139A1 - Prostate tumor polynucleotide and antigen compositions - Google Patents

Prostate tumor polynucleotide and antigen compositions

Info

Publication number
HK1029139A1
HK1029139A1 HK00107762A HK00107762A HK1029139A1 HK 1029139 A1 HK1029139 A1 HK 1029139A1 HK 00107762 A HK00107762 A HK 00107762A HK 00107762 A HK00107762 A HK 00107762A HK 1029139 A1 HK1029139 A1 HK 1029139A1
Authority
HK
Hong Kong
Prior art keywords
present
polypeptides
prostate tumor
compositions
methods
Prior art date
Application number
HK00107762A
Other languages
English (en)
Inventor
Laus Reiner
Shapero H Michael
Tsavaler Larisa
Original Assignee
Dendreon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Corp filed Critical Dendreon Corp
Publication of HK1029139A1 publication Critical patent/HK1029139A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK00107762A 1997-08-20 2000-12-04 Prostate tumor polynucleotide and antigen compositions HK1029139A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5611097P 1997-08-20 1997-08-20
US09/112,096 US6194152B1 (en) 1997-08-20 1998-07-09 Prostate tumor polynucleotide compositions and methods of detection thereof
PCT/US1998/017058 WO1999009166A2 (en) 1997-08-20 1998-08-18 Prostate tumor polynucleotide and antigen compositions

Publications (1)

Publication Number Publication Date
HK1029139A1 true HK1029139A1 (en) 2001-03-23

Family

ID=26734980

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107762A HK1029139A1 (en) 1997-08-20 2000-12-04 Prostate tumor polynucleotide and antigen compositions

Country Status (11)

Country Link
US (1) US6194152B1 (de)
EP (1) EP1005549B1 (de)
JP (1) JP4234319B2 (de)
AT (1) ATE386117T1 (de)
AU (1) AU744875B2 (de)
CA (1) CA2300364C (de)
DE (1) DE69839123T2 (de)
ES (1) ES2301208T3 (de)
HK (1) HK1029139A1 (de)
NZ (1) NZ503404A (de)
WO (1) WO1999009166A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381407B1 (en) 1996-03-25 2008-06-03 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
US6962981B1 (en) * 1996-03-25 2005-11-08 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
US6541212B2 (en) * 1997-03-10 2003-04-01 The Regents Of The University Of California Methods for detecting prostate stem cell antigen protein
US20040009478A1 (en) * 1998-03-10 2004-01-15 Metagen Gesellschaft Fur Genomforschung Mbh Human nucleic acid sequences from prostate tumor tissue
DE19811193A1 (de) * 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatatumorgewebe
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7063959B1 (en) * 1998-12-30 2006-06-20 Beth Israel Deaconess Medical Center, Inc. Compositions of the SOC/CRAC calcium channel protein family
AU776672B2 (en) * 1998-12-30 2004-09-16 Beth Israel Deaconess Medical Center Characterization of a calcium channel family
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
AU4791901A (en) * 2000-03-30 2001-10-15 Dendreon Corp Compositions and methods for dendritic cell-based immunotherapy
ATE396266T1 (de) * 2000-07-28 2008-06-15 Ulrich Wissenbach Trp8 krebsmarker
JP4520631B2 (ja) * 2000-11-22 2010-08-11 松本油脂製薬株式会社 耐久透水性付与剤及びその繊維
CA2450113A1 (en) * 2001-06-13 2002-12-19 Novartis Ag Vanilloid receptor-related nucleic acids and polypeptides
ES2372321T3 (es) 2001-06-20 2012-01-18 Genentech, Inc. Composiciones y métodos para el diagnóstico y tratamiento de un tumor de pulmón.
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7371841B2 (en) 2002-01-25 2008-05-13 Regents Of The University Of California Methods of modulating cold sensory perception
DE10215321A1 (de) * 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh Trp-p8 Splice Varianten und regulatorische RNA
AU2003241127A1 (en) * 2002-06-12 2003-12-31 Gavish-Galilee Bio Applications Ltd MEMBRANE-ANCHORED Beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
US20080286312A1 (en) * 2002-06-12 2008-11-20 Gavish-Galilee Bio Applications Ltd. Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
US20040092807A1 (en) * 2002-11-07 2004-05-13 Amos Breskin System and method for cancer detection
DE10259619A1 (de) * 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
US6893626B2 (en) * 2003-02-18 2005-05-17 Edward T. Wei Compositions for TRP-M8 binding and radioreceptor methods therewith
PT1675956E (pt) * 2003-10-21 2010-11-04 Merck Serono Sa Sequência mínima de adn que actua como um isolador de cromatina e sua utilização na expressão de proteína
GB0407175D0 (en) * 2004-03-30 2004-05-05 Paradigm Therapeutics Ltd Ion channel
JP5249587B2 (ja) * 2005-02-18 2013-07-31 メダレックス， インク． フコシル残基を欠く前立腺特異的膜抗原（ｐｓｍａ）に対するモノクローナル抗体
WO2006089230A2 (en) * 2005-02-18 2006-08-24 Medarex, Inc. Human monoclonal antibodies to prostate specific membrane antigen (psma)
GB201021499D0 (en) * 2010-12-20 2011-02-02 Loxbridge Res Llp Detection of quantative genetic differnces
WO2014087217A1 (en) 2012-12-03 2014-06-12 Subhadra Dravida Allogenic mesendritic vector for ovarian cancer
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0668777T3 (da) 1992-11-05 2007-02-19 Sloan Kettering Inst Cancer Prostataspecifikt membran-antigen
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
WO1995030758A1 (en) 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide
US5614372A (en) 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5830649A (en) * 1995-05-26 1998-11-03 Smithkline Beecham Corporation Human galactokinase gene
US5710007A (en) 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
WO1999009166A3 (en) 1999-06-03
EP1005549B1 (de) 2008-02-13
EP1005549A2 (de) 2000-06-07
AU9021898A (en) 1999-03-08
WO1999009166A2 (en) 1999-02-25
NZ503404A (en) 2002-03-01
AU744875B2 (en) 2002-03-07
ES2301208T3 (es) 2008-06-16
DE69839123D1 (de) 2008-03-27
ATE386117T1 (de) 2008-03-15
US6194152B1 (en) 2001-02-27
JP2001514889A (ja) 2001-09-18
CA2300364A1 (en) 1999-02-25
DE69839123T2 (de) 2009-02-05
CA2300364C (en) 2014-06-10
JP4234319B2 (ja) 2009-03-04

Similar Documents

Publication Publication Date Title
HK1029139A1 (en) Prostate tumor polynucleotide and antigen compositions
WO2001057182A3 (en) Nucleic acids, proteins, and antibodies
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
WO1998010069A3 (en) E25a protein, methods for production and use thereof
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
ATE266203T1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
WO2003083078A3 (en) Novel human cell surface protein with immunoglobulin folds, bgs-19
WO2000007545A3 (en) Apoptosis proteins
DE60018964D1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2001055300A3 (en) Nucleic acids, proteins, and antibodies
DE69531167D1 (de) Verfahren zum nachweis und therapie von schuppenartigen zellkarzinomen und blasen-karzinomen insbesondere zur bestimmung der anwesenheit und behandlung von minimalen resterkrankungen, micrometastasierung oder der verbreitung von solchen karzinomtypen
WO2001055313A3 (en) Nucleic acids, proteins, and antibodies
EP1243653A3 (de) E25a Protein, Methoden zur Herstellung und Verwendung
EP1323823A3 (de) Sekretorisches Peptir-9 von Säugern, dagegen gerichtete Antikörper und deren Verwendung

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180817